Prostate Cancer and Translational Research

Douglas Middleton Dahl, MD, is chief of the Division of Urologic Oncology at Massachusetts General Hospital, as well as director of Robotic Surgery, and an associate professor at Harvard Medical School. In this video, he discusses his translational research on prostate cancer cells, and explains how this work will advance patient care. Learn about more advances in urologic care at Mass General: https://advances.massgeneral.org/urol...